Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aernoud T L Fiolet

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Clinical Drug Investigation|October 8, 2022
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) TrialAmber van Broekhoven, Niekbachsh Mohammadnia, Max J M Silvis, et al.
Journal of the American College of Cardiology|September 2, 2025
Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 TrialNiekbachsh Mohammadnia, Liying Xue, Lucas T W Vestjens, et al.
Journal of the American College of Cardiology|August 27, 2021
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary SyndromeTjerk S J Opstal, Aernoud T L Fiolet, Amber van Broekhoven, et al.
European Journal of Preventive Cardiology|July 6, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseasePascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet, et al.
European Heart Journal|May 2, 2025
Colchicine for secondary prevention of vascular events: a meta-analysis of trialsMarc-André d'Entremont, Michiel H F Poorthuis, Aernoud T L Fiolet, et al.
Eclinicalmedicine|October 21, 2024
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trialsAernoud T L Fiolet, Michiel H F Poorthuis, Tjerk S J Opstal, et al.
The New England Journal of Medicine|September 1, 2020
Colchicine in Patients with Chronic Coronary DiseaseStefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical Drug Investigation|October 8, 2022
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) TrialAmber van Broekhoven, Niekbachsh Mohammadnia, Max J M Silvis, et al.
Journal of the American College of Cardiology|September 2, 2025
Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 TrialNiekbachsh Mohammadnia, Liying Xue, Lucas T W Vestjens, et al.
Journal of the American College of Cardiology|August 27, 2021
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary SyndromeTjerk S J Opstal, Aernoud T L Fiolet, Amber van Broekhoven, et al.
European Journal of Preventive Cardiology|July 6, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseasePascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet, et al.
European Heart Journal|May 2, 2025
Colchicine for secondary prevention of vascular events: a meta-analysis of trialsMarc-André d'Entremont, Michiel H F Poorthuis, Aernoud T L Fiolet, et al.
Eclinicalmedicine|October 21, 2024
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trialsAernoud T L Fiolet, Michiel H F Poorthuis, Tjerk S J Opstal, et al.
The New England Journal of Medicine|September 1, 2020
Colchicine in Patients with Chronic Coronary DiseaseStefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, et al.
Pageof 4